Literature DB >> 21915891

UPLC-MS/MS method for bioequivalence study of oral drugs of meldonium.

Yuriy V Pidpruzhnykov1, Valerii E Sabko, Volodymyr V Iurchenko, Igor A Zupanets.   

Abstract

A rapid and simple method based on ultra-performance liquid chromatography on a hydrophilic interaction chromatography column with tandem mass-selective detection (UPLC-MS/MS) to determine meldonium in human plasma was developed. The calibration curve acquired in the range of 10-6000 ng/mL had quadratic form. Method validation proved the conformity of its properties (selectivity, matrix effect, lower limit of quantification, accuracy, precision and recovery) with the established requirements. The stability tests necessary for bioanalytical studies were performed. For the first time, the method was successfully applied to the bioequivalence studies of generic and brand name oral drugs of meldonium in capsules. Based on data from 24 volunteers, it was determined that the mean pharmacokinetic curves of the drugs are characterized by a double peak profile.
Copyright © 2011 John Wiley & Sons, Ltd.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21915891     DOI: 10.1002/bmc.1703

Source DB:  PubMed          Journal:  Biomed Chromatogr        ISSN: 0269-3879            Impact factor:   1.902


  2 in total

1.  Mildronate (Meldonium) in professional sports - monitoring doping control urine samples using hydrophilic interaction liquid chromatography - high resolution/high accuracy mass spectrometry.

Authors:  Christian Görgens; Sven Guddat; Josef Dib; Hans Geyer; Wilhelm Schänzer; Mario Thevis
Journal:  Drug Test Anal       Date:  2015-04-05       Impact factor: 3.345

2.  Development and validation of an UHPLC-Orbitrap-HRMS method for rapid determination of endogenous L-carnitine in patients on hemodialysis/peritoneal dialysis and its application to promote rational drug use.

Authors:  Wen-Ting Jiang; Liu-Xing Tang; Jie Pan; Cun-Jin Su; Zhu Shen; Zhan-Hong Hu; Zhou-Bing Zhan; Ai-Ming Shi
Journal:  Ann Transl Med       Date:  2022-01
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.